Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2021Bioorganic & Medicinal Chemistry LettersOpen Access

Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKatarzyna Kucwaj‐BryszJagiellonian UniversityHBHanna BaltrukevichKCKinga Czarnota

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kucwaj‐Brysz et al. (2021) studied this question.

synapsesocial.com/papers/6a0d9edacae7912d2fa52105https://doi.org/10.1016/j.bmcl.2021.128275
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phases of Aβ-deposition in the human brain and its relevance for the development of AD2002 · 3,614 citations
  2. 2How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population‐based study2008 · 73 citations
  3. 3Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders2016 · 2 citations
  4. 4Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β2018 · 361 citations